Kazuhiro Iwadoh

Kazuhiro Iwadoh

Auto-generated profile, based on publicly available information

Kazuhiro Iwadoh

Department of Transplant Surgery, Mita Hospital, International University of Health and Welfare, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in Transplant International
Verified
Journal Article
Closed access
PDF file
YOYoshitsugu Obi
Yoshitsugu Obi
NINaotsugu Ichimaru
Naotsugu Ichimaru
YSYusuke Sakaguchi
Yusuke Sakaguchi
KIKazuhiro Iwadoh
Kazuhiro Iwadoh
DIDaisuke Ishii
Daisuke Ishii
TIthe CANDLE‐KIT Trial Investigators
the CANDLE‐KIT Trial Investigators
Anemia and vitamin D deficiency are associated with allograft failure, and hence, are potential therapeutic targets among kidney transplant recipients (KTRs). We conducted a multicenter, two‐by‐two factorial, open‐label, randomized clinical trial to examine the effects of anemia correction and vitamin D supplementation on 2‐year change in eGFR among KTRs (CANDLE‐KIT). We enrolled 153 patients with anemia and >1‐year history of transplantation across 23 facilities in Japan, and randomly assigned them to either a high or low hemoglobin target (>12.5 vs. <10.5 g/dL) and to either cholecalciferol 1000 IU/day or control. This trial was terminated early based on the planned interim intention‐to‐treat analyses (α=0.034). Among 125 patients who completed the study, 2‐year decline in eGFR was smaller in the high vs. low hemoglobin group (i.e., ‐1.6±4.5 vs. ‐4.0±6.9 mL/min/1.73 m2; P=0.021), but did not differ between the cholecalciferol and control groups. These findings were supported by the fully‐adjusted mixed effects model evaluating the rate of eGFR decline among all 153 participants. There were no significant between‐group differences in all‐cause death or the renal composite outcome in either arm. In conclusion, aggressive anemia correction showed a potential to preserve allograft kidney function.

25 August 2023 in Liver Transplantation
Verified
Journal Article
Closed access
MAMiho Akabane
Miho Akabane
KIKazuhiro Iwadoh
Kazuhiro Iwadoh
MMMarc Melcher
Marc Melcher
KSKazunari Sasaki
Kazunari Sasaki
An abstract is unavailable. This article is available as a PDF only.

14 November 2025 in The Lancet Digital Health
Verified
Journal Article
Open access
RYRintaro Yanagawa
Rintaro Yanagawa
KIKazuhiro Iwadoh
Kazuhiro Iwadoh
TNToshihiro Nakayama
Toshihiro Nakayama
DFDaniel J Firl
Daniel J Firl
CWChase J Wehre
Chase J Wehre
KSKazunari Sasaki
Kazunari Sasaki
The number of liver transplants from donors after the circulatory determination of death continues to increase, helping to alleviate the existing organ shortage. However, the rate of attempted but subsequently terminated procurements, known as futile procurements, remains high-mainly because many potential donors do not progress to death within a timeframe after extubation that maintains the suitability of the organ for donation. Futile procurements pose considerable financial and workload burdens to the transplant system. We aimed to develop and validate a machine-learning model to better predict progression to death and reduce futile procurements in cases of donation after circulatory death (DCD). This study included data from 2221 donors from six centres in the USA. Using a retrospective dataset obtained from 1616 donors between December 1, 2022, and June 30, 2023, we developed a prediction model using the Light Gradient Boosting Machine (LightGBM) framework, with neurological, biochemical, respiratory, and circulatory parameters as predictors. The model was validated retrospectively with data from 398 donors (July 1-Aug 31, 2023) and prospectively with data from 207 donors (March 1-Sept 30, 2024). The performance of the model was evaluated through the area under the receiver operating characteristic curve (AUC), accuracy, futile procurement rate, and missed opportunity rate. We also compared the performance of the model with that of two existing risk-prediction tools (the DCD-N score and the Colorado Calculator) and surgeon predictions. Of the 2221 DCD donors in this study, 1260 progressed to death, 927 of whom died within 30 min after extubation. Cross-validation of the LightGBM model yielded AUCs for predicting donor progression to death of 0·833 (95% CI 0·798-0·868) at 30 min, 0·801 (0·767-0·834) at 45 min, and 0·805 (0·770-0·841) at 60 min after extubation. This performance was maintained in both retrospective (0·834 [0·772-0·891], 0·819 [0·757-0·870], and 0·799 [0·737-0·855]) and prospective (0·831 [0·768-0·885], 0·812 [0·749-0·874], and 0·805 [0·740-0·868]) validation cohorts. Compared with surgeon predictions, the LightGBM model had lower futile procurement rates (0·195 vs 0·078, respectively), higher accuracy in cases of poor intersurgeon agreement (0·08 vs 0·29) at 30 min, and similar missed opportunity rates (0·155 vs 0·167). By contrast, the DCD-N score had AUCs of 0·799 (95% CI 0·730-0·860) at 30 min, 0·760 (0·695-0·824) at 45 min, and 0·739 (0·668-0·801) at 60 min, and the Colorado Calculator had AUCs of 0·694 (0·616-0·768), 0·669 (0·596-0·742), and 0·663 (0·585-0·736) at the same timepoints. We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance the accuracy of the prediction of progression to death in DCD donors and reduce futile procurements. Such improvements have the potential to alleviate some of the financial and operational burdens on the transplant community. Further improvements are needed to decrease missed opportunities and improve the overall accuracy of such models. None.

28 April 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KIKazuhiro Iwadoh
Kazuhiro Iwadoh
INIchiro Nakajima
Ichiro Nakajima
IKIchiro Koyama
Ichiro Koyama
KNKosaku Nitta
Kosaku Nitta
SFShohei Fuchinoue
Shohei Fuchinoue
We developed a preoperative assessment system to predict surgical workload in hand-assisted laparoscopic donor nephrectomy (HALDNx) using the normal-based linear discriminant rule (NLDR). A total of 128 cases of left HALDNx performed by a single operator were used as training data. Surgical workload was measured by operative time. The optimized model had 9 explanatory variables: age, total protein, total cholesterol, number of renal arteries (numberRA), 4 variables of perinephric fat (PNF), and thickness of subcutaneous fat. This model was validated using cross-validation and the .632 estimator to estimate discrimination rates with future test data. PNF and numberRA were the predominant factors affecting workload followed by the computed tomography value of PNF, body weight, and male sex. The estimated accuracy of the prediction system was 94.6%. The complication rate was 9.38% and did not correlate with surgical workload. We also made our program available online for constructing assessment functions from other cohort data. In conclusion, the surgical workload of HALDNx could be predicted with PNF and numberRA as the dominant risk factors.

9 October 2023 in Liver Transplantation
Verified
Journal Article
Closed access
MAMiho Akabane
Miho Akabane
KIKazuhiro Iwadoh
Kazuhiro Iwadoh
MMMarc Melcher
Marc Melcher
KSKazunari Sasaki
Kazunari Sasaki
An abstract is unavailable. This article is available as a PDF only.